Dow Up 0.03% Nasdaq Down 0.07%

More On OXBT

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Tenax Therapeutics, Inc. (OXBT)

-NasdaqCM
4.04 Up 0.02(0.50%) Sep 18 - Nasdaq Real Time Price
Prev Close:4.04
Open:4.04
Bid:N/A
Ask:N/A
1y Target Est:10.50
Beta:0.68
Next Earnings Date:N/A
Day's Range:4.00 - 4.11
52wk Range:1.19 - 9.75
Volume:188,777
Avg Vol (3m):214,059
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OXBT

Comparison

Symbol% ChgMkt Cap
OXBTUp 0.50%N/A
NVSUp 0.65%228.48B
PFEDown 0.10%188.58B
RHHBYUp 0.05%250.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback